TrialCancer2025

Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.

Ticiana A Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.